Top Suppliers:I want be here


27262-48-2

27262-48-2 structure
27262-48-2 structure

Name levobupivacaine hydrochloride (anhydrous)
Synonyms (S)-(-)-BUPIVACAINEHYDROCHLORIDEMONOHYDRATE
API Levobupivacaine hydrochloride Powder Dosage Usage Effect and Benefit
L-BUPIVACAINE HYDROCHLORIDE
LEVOBUPIVACAINE HYDROCHLORIDE
(S)-1-Butyl-N-(2,6-diMethylphenyl)piperidine-2-cboxaMide hydrochloride
Levobupivacaine hydrochloride 27-2
Bupivacaine Impurity 1
(S)-(-)-Bupivacaine
Levobupivacaine HCl|||(S)-(-)-Bupivacaine HCl|||(S)-(-)-Bupivacaine monohydrochloride
BUPIVACAINE HYDROCHLORIDE, MONOHYDRATE
Levobupivacaine hydrochloride S-(-)-1-Butyl-2',6'-pipecoloxylidide hydrochloride
Levobupivacaine hydrochloride //BP
(2S)-1-butyl-N-(2,6-dimethylphenyl)-2-piperidinecboxamide, hydrochloride (1:1)
2-Piperidinecboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, (2S)
LEVAMISOLHCLSALT
s-(-)-1-butyl-2',6'-pipecoloxylidide hydrochloride
bupicainehydrochloride(-)
Levobupivacaine hydrochloride, 10 mM in DMSO
A Ropivacaine Impurity A
Levobupivacaine HCI
(S)-Bupivacaine HCl (Levobupivacaine HCl)
(S)-Bupivacaine hydrochloride
BUPIVACAINE HCL
(S)-(-)-Bupivacaine monohydrochloride
(S)-(-)-1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecboxamide hydrochloride
2-Piperidinecboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, (S)
MFCD01704265
(2S)-1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide hydrochloride (1:1)
(2S)-1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide hydrochloride (1:1)
(S)-(-)-1-BUTYL-2-(2,6-XYLYLCBAMOYL)-PIPERIDINE HYDROCHLORIDE
(S)-(-)-1-N-BUTYL-2',6'-DIMETHYL-2-PIPERIDINCBOXANILID HYDROCHLORIDE
Levobupivacainehydrochloride
(S)-(-)-BUPIVACAINE HCL
Levobupivacaine Hydrochloride
Levobupivacaine HCl (S-Bupivacaine)
Levobupivacaine (hydrochloride)
Levobupivacaine HCl
(-)-Bupivacaine hydrochloride
(s)-1-butyl-n-(2,6-dimethylphenyl)-2-piperidinecboxamidemonohydrochloride
Chirocaine
Levobupivacaine hcl Anesthetic Raw Powder
1-butyl-piperidine-2-carboxylic acid-(2,6-dimethyl-anilide),hydrochloride
2',6'-Pipecoloxylidide, 1-butyl-, hydrochloride, (-)
(S)-(-)-BUPIVACAINE HYDROCHLORIDE
Levo-Bupivacaine hydrochlorideQ: What is Levo-Bupivacaine hydrochloride Q: What is the CAS Number of Levo-Bupivacaine hydrochloride
Ropivacaine Impurity A HBr
6’-pipecoloxylidide,1-butyl-,hydrochloride,(-)-2
LEVOBUPIVACAINE HCL
(S)-(-)-Bupivacaine hydrochloride
(S)-Bupivacaine
Ropivacaine Impurity A()
2-Piperidinecboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, monohydrochloride, (S)
levobupivacaine monohydrochloride
L-(-)-Bupivacaine
Levobupivacaine HCL //Levobupivacaine
(RS)-bupivacaine hydrochloride
bupivacaine.hydrochloride
2-Piperidinecboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, monohydrochloride, (2S)
2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, (2S)-, hydrochloride (1:1)
TIMTEC-BB SBB001337
Levobupivacaine hydrochloride Impurities
(s)-1-butyl-2’,6’-piperidinecboxamidemonohydrochloride
(-)-Bupicaine Hydrochloride
Boiling Point 423.4ºC at 760 mmHg
Melting Point 254 °C (dec.)(lit.)
Molecular Formula C18H29ClN2O
Molecular Weight 324.889
Flash Point 209.9ºC
Exact Mass 324.196838
PSA 23.55000
LogP 4.74080
Vapour Pressure 2.24E-07mmHg at 25°C

CHEMICAL IDENTIFICATION

RTECS NUMBER :
TK6120000
CHEMICAL NAME :
2',6'-Pipecoloxylidide, 1-butyl-, hydrochloride, (-)-
CAS REGISTRY NUMBER :
27262-48-2
LAST UPDATED :
198209
DATA ITEMS CITED :
4
MOLECULAR FORMULA :
C18-H28-N2-O.Cl-H
MOLECULAR WEIGHT :
324.94
WISWESSER LINE NOTATION :
T6NTJ A4 BVMR B1 F1 &GH

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
63 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- Volume(issue)/page/year: 200,359,1972
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
18 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- Volume(issue)/page/year: 200,359,1972
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
5100 ug/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- Volume(issue)/page/year: 200,359,1972
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Parenteral
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
207 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- Volume(issue)/page/year: 200,359,1972
Symbol GHS07
GHS07
Signal Word Warning
Hazard Statements H315-H319-H335
Precautionary Statements P261-P305 + P351 + P338
Hazard Codes T+: Very toxic;Xn: Harmful;
Risk Phrases R20/21/22
Safety Phrases S22-S36/37/39-S45-S36/37-S53
RIDADR UN 2811 6.1/PG 2
WGK Germany 3
RTECS TK6125000
HS Code 2942000000
HS Code 2942000000
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.